cs-riskfactor-eu-pcsp vs cs-riskfactor-eu-pcsp

CodeSystem Comparison between http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp vs http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp

Messages

Error

CodeSystem.version

Values for version differ: '0.1.0' vs '0.2.0'

Information

CodeSystem.status

Values for status differ: 'active' vs 'draft'

Information

CodeSystem.date

Values for date differ: '2023-01-26T09:50:21+01:00' vs '2024-09-11T13:25:13+00:00'

Warning

CodeSystem.concept.where(code='5.1').display

Changed value for display: 'RT between 15 and 35 Gy to a vol exposing the heart' vs 'RT >=12 Gy to a vol exposing the testicles'

Information

CodeSystem.concept.where(code='5.1').definition

Changed value for definition: 'RT between 15 and 35 Gy to a vol exposing the heart' vs 'RT >=12 Gy to a vol exposing the testicles'

Warning

CodeSystem.concept.where(code='16.2').display

Changed value for display: 'Hydrocephalus or cerebrospinal fluid shunt (Risk factor for GHD)' vs 'Hydrocephalus or cerebrospinal fluid shunt(Risk factor for GHD)'

Information

CodeSystem.concept.where(code='16.2').definition

Changed value for definition: 'Hydrocephalus or cerebrospinal fluid shunt (Risk factor for GHD)' vs 'Hydrocephalus or cerebrospinal fluid shunt(Risk factor for GHD)'

Warning

CodeSystem.concept.where(code='21.2').display

Changed value for display: 'RT to a vol exposing the brain ANY DOSE' vs 'RT to a vol exposing the brain ANY DOSE'

Information

CodeSystem.concept.where(code='21.2').definition

Changed value for definition: 'RT to a vol exposing the brain ANY DOSE' vs 'RT to a vol exposing the brain ANY DOSE'

Warning

CodeSystem.concept.where(code='30.1').display

Changed value for display: 'RT to a vol exposing the gastro-intestinal tract' vs 'RT to a vol exposing the gastro-intestinal tract'

Information

CodeSystem.concept.where(code='30.1').definition

Changed value for definition: 'RT to a vol exposing the gastro-intestinal tract' vs 'RT to a vol exposing the gastro-intestinal tract'

Warning

CodeSystem.concept.where(code='32.5').display

Changed value for display: 'BCNU Carmustine' vs 'BCNU Carmustine'

Information

CodeSystem.concept.where(code='32.5').definition

Changed value for definition: 'BCNU Carmustine' vs 'BCNU Carmustine'

Warning

CodeSystem.concept.where(code='32.6').display

Changed value for display: 'CCNU Lomustine' vs 'CCNU Lomustine'

Information

CodeSystem.concept.where(code='32.6').definition

Changed value for definition: 'CCNU Lomustine' vs 'CCNU Lomustine'

Warning

CodeSystem.concept.where(code='38.1').display

Changed value for display: 'Any RT including TBI' vs 'Any RT including TBI (predominantly in the RT field)'

Information

CodeSystem.concept.where(code='38.1').definition

Changed value for definition: 'Any RT including TBI' vs 'Any RT including TBI (predominantly in the RT field)'

Metadata

Name	Value	Comments
caseSensitive	true
compositional
content	complete
copyright
date	2023-01-26T09:50:21+01:00	2024-09-11T13:25:13+00:00	Values Differ
description	Risk Factors used by the PCSP algorithm
experimental	false
hierarchyMeaning
jurisdiction
jurisdiction[0]	http://unstats.un.org/unsd/methods/m49/m49.htm#150
name	CsRiskFactorPcsp
publisher	PanCareSurPass Project
purpose
status	active	draft	Values Differ
title	Risk Factors
url	http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp
version	0.1.0	0.2.0	Values Differ
versionNeeded

Name

Value

Comments

caseSensitive

true

compositional

content

complete

date

2023-01-26T09:50:21+01:00

2024-09-11T13:25:13+00:00

Values Differ

description

Risk Factors used by the PCSP algorithm

experimental

false

hierarchyMeaning

jurisdiction

jurisdiction[0]

http://unstats.un.org/unsd/methods/m49/m49.htm#150

name

CsRiskFactorPcsp

publisher

PanCareSurPass Project

purpose

status

active

draft

Values Differ

title

Risk Factors

url

http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp

version

0.1.0

0.2.0

Values Differ

versionNeeded

Concepts

Code	Display	Comments
1.1	RT to a vol exposing the thyroid gland
1.2	TBI
1.3	MIBG therapy (I-131 MIBG therapy)
2.1	RT >= 10 Gy to a vol exposing the breasts
2.2	OR upper abdominal field radiation that can extend above the diaphragm likely exposing breast tissue at a young age
3.1	RT >= 35 Gy to a vol exposing the heart
3.2	Anthracyclines (doxorubicin isotoxic equivalents)>= 250 mg/m2
3.3	RT >= 15 Gy to a vol exposing the heart AND Anthracyclines (doxorubicin isotoxic equivalents)>= 100 mg/m2
4.1	Alkylating agents
4.2	RT to a vol exposing the testes
5.1	RT between 15 and 35 Gy to a vol exposing the heart	RT >=12 Gy to a vol exposing the testicles	display changed from left to right definition changed from left to right
6.1	RT to a vol exposing the testes or pelvis		Removed this concept
6.3	Surgery to the spinal cord, sympathetic nerves or pelvis
6.4	Hypogonadal
7.2	RT to a vol exposing the ovaries
8.1	RT >= 30 Gy to a vol exposing the head or the brain
8.2	Cisplatin (with or without carboplatin > 1500 mg/m2)
9.1	RT to a vol exposing the pancreas
10.2	HSCT
11.1	RT to a volume exposing the hypothalamus or pituatary gland
11.3	Hypothalamic or pituitary tumour
11.4	Neurosurgery of the hypothalamus or pituitary gland
12.1	RT to a vol exposing the kidneys, heart and associated large vessels
12.3	Nephrectomy
12.4	Ifosfamide
12.5	Platinium based chemotherapy
12.6	Nitrosureas
12.7	Immunosuppressives treatment and prolonged steroids as anticancer treatment (at least 4 weeks, continuously)
13.1	Cranial and/or spinal RT
13.3	Methotrexate
13.4	Gonadal failure
13.5	Growth hormone deficiency
13.6	Prolonged (at least 4 weeks, continuously) corticosteroids as anti-cancer treatment
14.3	High dose RT
15.1	Radiotherapy to a vol exposing the HP region >= 30 Gy
15.2	Surgery near or within the HP region
15.3	CNS tumours near or within the HP region
16.1	Radiotherapy to a vol exposing the HP region< 30 Gy
16.2	Hydrocephalus or cerebrospinal fluid shunt (Risk factor for GHD)	Hydrocephalus or cerebrospinal fluid shunt(Risk factor for GHD)	display changed from left to right definition changed from left to right
17.1	Radiotherapy to a vol exposing the HP region
17.3	Surgery near or within the HP region		Removed this concept
18.1	Radiotherapy to a vol exposing the HP region		Removed this concept
18.3	Surgery near or within the HP region		Removed this concept
19.1	RT to a vol exposing the thyroid gland		Removed this concept
19.3	Radioiodine therapy (I-131 ablation therapy)
19.5	Allogenic HSCT
19.6	Total thyroidectomy
20.1	RT to a vol exposing the head, brain or neck
21.1	History of a central nervous system tumor
21.2	RT to a vol exposing the brain ANY DOSE	RT to a vol exposing the brain ANY DOSE	display changed from left to right definition changed from left to right
21.4	Brain surgery
21.5	High dose cytarabine IV (intravenous)
21.6	High dose MTX IV
21.7	Any Chemotherapy IT (intrathecal)
22.1	Vinca-Alkaloids
22.2	Cisplatin or carboplatin
23.1	RT to a vol exposing the lens
24.1	RT to a vol exposing the eye and orbit
24.3	Radioiodine therapy (I-131 ablation therapy)		Removed this concept
25.1	RT to a vol exposing the craniofacial area, especially after high doses and at a young age
25.3	Surgery to the face, especially at a young age
26.1	Surgery of the spine
26.2	Surgery of the chest (Does not include CVC pose)
26.3	RT to a vol exposing the spine
26.4	Spinal or paraspinal malignancies
27.1	Cyclophosphamide
27.3	RT to a vol exposing the bladder
27.5	Cystectomy
27.6	Hysterectomy
27.7	Pelvic surgery
27.8	Spinal cord surgery
28.1	RT to a vol exposing the uterus only female
29.1	RT to a vol exposing the oral cavity or salivary glands
29.4	Chemotherapy
30.1	RT to a vol exposing the gastro-intestinal tract	RT to a vol exposing the gastro-intestinal tract	display changed from left to right definition changed from left to right
30.3	Oesophageal surgery
30.4	Abdominal surgery
30.5	With a history of chronic GVHD
31.1	Anthracyclines (doxorubicin isotoxic equivalents) <100 mg/m2
32.1	RT to a vol exposing the lungs
32.3	Bleomycin
32.4	Busulfan
32.5	BCNU Carmustine	BCNU Carmustine	display changed from left to right definition changed from left to right
32.6	CCNU Lomustine	CCNU Lomustine	display changed from left to right definition changed from left to right
32.7	Thoracic surgery
33.1	Cisplatin Any dose
33.3	Carboplatin Any dose
34.1	RT to a volume exposing the liver
34.3	HSCT (irrespective of GVHD)
34.5	Mercaptopurine Thioguanine
34.6	Dactinomycin
34.8	Chronic viral hepatitis
34.9	Sinusoidal obstruction syndrome
34.10	Chronic GVHD
34.11	Liver surgery
35.2	Multiple red blood cell transfusions
36.1	Splenectomy
36.2	RT >= 10 Gy to a vol exposing the spleen
36.4	Autologus HSCT conditioned with TBI
37.1	Hereditary cancer sd
38.1	Any RT including TBI	Any RT including TBI (predominantly in the RT field)	display changed from left to right definition changed from left to right
39.1	RT to a vol exposing the colon and rectum
40.1	RT to a vol exposing the oral cavity
41.2	Anthracyclines and/or Mitoxantrone
41.3	Epipodophyllotoxins or autologous
41.4	Autologous haematopoietic stem cell transplant
42.1	Ciclofosfamide, Ifosfamide (particularly if they have a history of severe hemorrhagic cystitis)
42.2	RT to a vol exposing the bladder		Removed this concept
44.1	RT to a vol exposing the lungs		Removed this concept
45.1	RT to a vol exposing the head or brain
46.2	Anthracyclines (doxorubicin isotoxic equivalents) between 100 and 250 mg/m2
47.1	RT to a vol exposing the kidney or urinary tract
4.3		Including TBI	Added this concept
13.7		HSCT, especially with an history of GVHD	Added this concept
17.5		hydrocephalus or cerebrospinal fluid shunt	Added this concept
33.2		Ifosfamide Any dose	Added this concept
35.1		HSCT (irrespective of GVHD)	Added this concept
36.3		Allogenic HSCT (with or without TBI)	Added this concept
38.2		HSCT Especially with a history of skin GvHD	Added this concept
46.1		RT between 15 and 35 Gy to a vol exposing the heart	Added this concept

Code

Display

Comments

1.1

RT to a vol exposing the thyroid gland

1.2

TBI

1.3

MIBG therapy (I-131 MIBG therapy)

2.1

RT >= 10 Gy to a vol exposing the breasts

2.2

OR upper abdominal field radiation that can extend above the diaphragm likely exposing breast tissue at a young age

3.1

RT >= 35 Gy to a vol exposing the heart

3.2

Anthracyclines (doxorubicin isotoxic equivalents)>= 250 mg/m2

3.3

RT >= 15 Gy to a vol exposing the heart AND Anthracyclines (doxorubicin isotoxic equivalents)>= 100 mg/m2

4.1

Alkylating agents

4.2

RT to a vol exposing the testes

5.1

RT between 15 and 35 Gy to a vol exposing the heart

RT >=12 Gy to a vol exposing the testicles

display changed from left to right
definition changed from left to right

6.1

RT to a vol exposing the testes or pelvis

Removed this concept

6.3

Surgery to the spinal cord, sympathetic nerves or pelvis

6.4

Hypogonadal

7.2

RT to a vol exposing the ovaries

8.1

RT >= 30 Gy to a vol exposing the head or the brain

8.2

Cisplatin (with or without carboplatin > 1500 mg/m2)

9.1

RT to a vol exposing the pancreas

10.2

HSCT

11.1

RT to a volume exposing the hypothalamus or pituatary gland

11.3

Hypothalamic or pituitary tumour

11.4

Neurosurgery of the hypothalamus or pituitary gland

12.1

RT to a vol exposing the kidneys, heart and associated large vessels

12.3

Nephrectomy

12.4

Ifosfamide

12.5

Platinium based chemotherapy

12.6

Nitrosureas

12.7

Immunosuppressives treatment and prolonged steroids as anticancer treatment (at least 4 weeks, continuously)

13.1

Cranial and/or spinal RT

13.3

Methotrexate

13.4

Gonadal failure

13.5

Growth hormone deficiency

13.6

Prolonged (at least 4 weeks, continuously) corticosteroids as anti-cancer treatment

14.3

High dose RT

15.1

Radiotherapy to a vol exposing the HP region >= 30 Gy

15.2

Surgery near or within the HP region

15.3

CNS tumours near or within the HP region

16.1

Radiotherapy to a vol exposing the HP region< 30 Gy

16.2

Hydrocephalus or cerebrospinal fluid shunt (Risk factor for GHD)

Hydrocephalus or cerebrospinal fluid shunt(Risk factor for GHD)

display changed from left to right
definition changed from left to right

17.1

Radiotherapy to a vol exposing the HP region

17.3

Surgery near or within the HP region

Removed this concept

18.1

Radiotherapy to a vol exposing the HP region

Removed this concept

18.3

Surgery near or within the HP region

Removed this concept

19.1

RT to a vol exposing the thyroid gland

Removed this concept

19.3

Radioiodine therapy (I-131 ablation therapy)

19.5

Allogenic HSCT

19.6

Total thyroidectomy

20.1

RT to a vol exposing the head, brain or neck

21.1

History of a central nervous system tumor

21.2

RT to a vol exposing the brain ANY DOSE

display changed from left to right
definition changed from left to right

21.4

Brain surgery

21.5

High dose cytarabine IV (intravenous)

21.6

High dose MTX IV

21.7

Any Chemotherapy IT (intrathecal)

22.1

Vinca-Alkaloids

22.2

Cisplatin or carboplatin

23.1

RT to a vol exposing the lens

24.1

RT to a vol exposing the eye and orbit

24.3

Radioiodine therapy (I-131 ablation therapy)

Removed this concept

25.1

RT to a vol exposing the craniofacial area, especially after high doses and at a young age

25.3

Surgery to the face, especially at a young age

26.1

Surgery of the spine

26.2

Surgery of the chest (Does not include CVC pose)

26.3

RT to a vol exposing the spine

26.4

Spinal or paraspinal malignancies

27.1

Cyclophosphamide

27.3

RT to a vol exposing the bladder

27.5

Cystectomy

27.6

Hysterectomy

27.7

Pelvic surgery

27.8

Spinal cord surgery

28.1

RT to a vol exposing the uterus only female

29.1

RT to a vol exposing the oral cavity or salivary glands

29.4

Chemotherapy

30.1

RT to a vol exposing the gastro-intestinal tract

display changed from left to right
definition changed from left to right

30.3

Oesophageal surgery

30.4

Abdominal surgery

30.5

With a history of chronic GVHD

31.1

Anthracyclines (doxorubicin isotoxic equivalents) <100 mg/m2

32.1

RT to a vol exposing the lungs

32.3

Bleomycin

32.4

Busulfan

32.5

BCNU Carmustine

display changed from left to right
definition changed from left to right

32.6

CCNU Lomustine

display changed from left to right
definition changed from left to right

32.7

Thoracic surgery

33.1

Cisplatin Any dose

33.3

Carboplatin Any dose

34.1

RT to a volume exposing the liver

34.3

HSCT (irrespective of GVHD)

34.5

Mercaptopurine Thioguanine

34.6

Dactinomycin

34.8

Chronic viral hepatitis

34.9

Sinusoidal obstruction syndrome

34.10

Chronic GVHD

34.11

Liver surgery

35.2

Multiple red blood cell transfusions

36.1

Splenectomy

36.2

RT >= 10 Gy to a vol exposing the spleen

36.4

Autologus HSCT conditioned with TBI

37.1

Hereditary cancer sd

38.1

Any RT including TBI

Any RT including TBI (predominantly in the RT field)

display changed from left to right
definition changed from left to right

39.1

RT to a vol exposing the colon and rectum

40.1

RT to a vol exposing the oral cavity

41.2

Anthracyclines and/or Mitoxantrone

41.3

Epipodophyllotoxins or autologous

41.4

Autologous haematopoietic stem cell transplant

42.1

Ciclofosfamide, Ifosfamide (particularly if they have a history of severe hemorrhagic cystitis)

42.2

RT to a vol exposing the bladder

Removed this concept

44.1

RT to a vol exposing the lungs

Removed this concept

45.1

RT to a vol exposing the head or brain

46.2

Anthracyclines (doxorubicin isotoxic equivalents) between 100 and 250 mg/m2

47.1

RT to a vol exposing the kidney or urinary tract

4.3

Including TBI

Added this concept

13.7

HSCT, especially with an history of GVHD

Added this concept

17.5

hydrocephalus or cerebrospinal fluid shunt

Added this concept

33.2

Ifosfamide Any dose

Added this concept

35.1

HSCT (irrespective of GVHD)

Added this concept

36.3

Allogenic HSCT (with or without TBI)

Added this concept

38.2

HSCT Especially with a history of skin GvHD

Added this concept

46.1

RT between 15 and 35 Gy to a vol exposing the heart

Added this concept